Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1923 1
1928 1
1930 1
1941 1
1944 1
1945 25
1946 110
1947 128
1948 193
1949 164
1950 267
1951 375
1952 376
1953 424
1954 386
1955 410
1956 388
1957 394
1958 361
1959 394
1960 416
1961 512
1962 545
1963 881
1964 1156
1965 939
1966 957
1967 1099
1968 1212
1969 1290
1970 1152
1971 1303
1972 1398
1973 1323
1974 1367
1975 1447
1976 1572
1977 1616
1978 1730
1979 1793
1980 1804
1981 1900
1982 2006
1983 2199
1984 2293
1985 2383
1986 2302
1987 2399
1988 2235
1989 2471
1990 2664
1991 2526
1992 2700
1993 2700
1994 2946
1995 3033
1996 2999
1997 3133
1998 3111
1999 3372
2000 3358
2001 3536
2002 3365
2003 3718
2004 3930
2005 4316
2006 4484
2007 4610
2008 5007
2009 5453
2010 6069
2011 6540
2012 6980
2013 7259
2014 7811
2015 8133
2016 8166
2017 8176
2018 8525
2019 8848
2020 9587
2021 9672
2022 8790
2023 8841
2024 9841
2025 3184

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227,172 results

Results by year

Filters applied: . Clear all
Page 1
Brain and other central nervous system tumor statistics, 2021.
Miller KD, Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G, Fuchs HE, Waite KA, Jemal A, Siegel RL, Barnholtz-Sloan JS. Miller KD, et al. CA Cancer J Clin. 2021 Sep;71(5):381-406. doi: 10.3322/caac.21693. Epub 2021 Aug 24. CA Cancer J Clin. 2021. PMID: 34427324 Free article.
Malignant brain tumor incidence rates declined by 0.8% annually from 2008 to 2017 for all ages combined but increased 0.5% to 0.7% per year among children and adolescents. Malignant brain tumor incidence is highest in males and non-Hispan …
Malignant brain tumor incidence rates declined by 0.8% annually from 2008 to 2017 for all ages combined but increased 0 …
Glioblastoma: Overview of Disease and Treatment.
Davis ME. Davis ME. Clin J Oncol Nurs. 2016 Oct 1;20(5 Suppl):S2-8. doi: 10.1188/16.CJON.S1.2-8. Clin J Oncol Nurs. 2016. PMID: 27668386 Free PMC article. Review.
BACKGROUND: Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults. Current treatment options at diagnosis are multimodal and include surgical resection, radiation, and chemotherapy. Significant advances in the understanding of t …
BACKGROUND: Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults. Current treatment opt …
Challenges in glioblastoma research: focus on the tumor microenvironment.
Bikfalvi A, da Costa CA, Avril T, Barnier JV, Bauchet L, Brisson L, Cartron PF, Castel H, Chevet E, Chneiweiss H, Clavreul A, Constantin B, Coronas V, Daubon T, Dontenwill M, Ducray F, Enz-Werle N, Figarella-Branger D, Fournier I, Frenel JS, Gabut M, Galli T, Gavard J, Huberfeld G, Hugnot JP, Idbaih A, Junier MP, Mathivet T, Menei P, Meyronet D, Mirjolet C, Morin F, Mosser J, Moyal EC, Rousseau V, Salzet M, Sanson M, Seano G, Tabouret E, Tchoghandjian A, Turchi L, Vallette FM, Vats S, Verreault M, Virolle T. Bikfalvi A, et al. Trends Cancer. 2023 Jan;9(1):9-27. doi: 10.1016/j.trecan.2022.09.005. Epub 2022 Nov 16. Trends Cancer. 2023. PMID: 36400694 Review.
Glioblastoma (GBM) is the most deadly type of malignant brain tumor, despite extensive molecular analyses of GBM cells. In recent years, the tumor microenvironment (TME) has been recognized as an important player and therapeutic target in GBM. ...In th …
Glioblastoma (GBM) is the most deadly type of malignant brain tumor, despite extensive molecular analyses of GBM cells. …
Emerging therapies for glioblastoma: current state and future directions.
Rong L, Li N, Zhang Z. Rong L, et al. J Exp Clin Cancer Res. 2022 Apr 15;41(1):142. doi: 10.1186/s13046-022-02349-7. J Exp Clin Cancer Res. 2022. PMID: 35428347 Free PMC article. Review.
Glioblastoma (GBM) is the most common high-grade primary malignant brain tumor with an extremely poor prognosis. Given the poor survival with currently approved treatments for GBM, new therapeutic strategies are urgently needed. ...In addition, techniques to …
Glioblastoma (GBM) is the most common high-grade primary malignant brain tumor with an extremely poor prognosis. Given …
[Medical Treatments for Malignant Brain Tumor].
Kitamura Y, Toda M. Kitamura Y, et al. Brain Nerve. 2023 May;75(5):561-566. doi: 10.11477/mf.1416202379. Brain Nerve. 2023. PMID: 37194532 Japanese.
Treatment of brain tumors, particularly malignant gliomas, is challenging using only surgical resection and radiation therapy, and medical treatment plays an important role in the management of these malignancies. ...Classical anticancer medications, such as nitroso …
Treatment of brain tumors, particularly malignant gliomas, is challenging using only surgical resection and radiation therapy, …
Wants and needs for involvement reported by relatives of patients with a malignant brain tumor: a scoping review.
Guldager R, Nordentoft S, Poulsen I, Aadal L, Loft MI. Guldager R, et al. JBI Evid Synth. 2023 Nov 1;21(11):2188-2210. doi: 10.11124/JBIES-22-00311. JBI Evid Synth. 2023. PMID: 37435678
OBJECTIVE: The objective of this scoping review was to identify and map the breadth of available evidence on relatives' wants and needs for involvement throughout the course of the disease in patients with a malignant brain tumor. INTRODUCTION: Patients diagn …
OBJECTIVE: The objective of this scoping review was to identify and map the breadth of available evidence on relatives' wants and needs for …
The Association of Human Herpesviruses with Malignant Brain Tumor Pathology and Therapy: Two Sides of a Coin.
Athanasiou E, Gargalionis AN, Boufidou F, Tsakris A. Athanasiou E, et al. Int J Mol Sci. 2021 Feb 24;22(5):2250. doi: 10.3390/ijms22052250. Int J Mol Sci. 2021. PMID: 33668202 Free PMC article. Review.
The role of certain viruses in malignant brain tumor development remains controversial. Experimental data demonstrate that human herpesviruses (HHVs), particularly cytomegalovirus (CMV), Epstein-Barr virus (EBV) and human herpes virus 6 (HHV-6), are implicate …
The role of certain viruses in malignant brain tumor development remains controversial. Experimental data demonstrate t …
Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy.
Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG. Wankhede M, et al. Expert Rev Clin Pharmacol. 2012 Mar;5(2):173-86. doi: 10.1586/ecp.12.1. Expert Rev Clin Pharmacol. 2012. PMID: 22390560 Free PMC article. Review.
Magnetic nanoparticles (MNPs) represent a promising nanomaterial for the targeted therapy and imaging of malignant brain tumors. Conjugation of peptides or antibodies to the surface of MNPs allows direct targeting of the tumor cell surface and potential disru …
Magnetic nanoparticles (MNPs) represent a promising nanomaterial for the targeted therapy and imaging of malignant brain tumor …
Calcium Channels and Associated Receptors in Malignant Brain Tumor Therapy.
Morrone FB, Gehring MP, Nicoletti NF. Morrone FB, et al. Mol Pharmacol. 2016 Sep;90(3):403-9. doi: 10.1124/mol.116.103770. Epub 2016 Jul 14. Mol Pharmacol. 2016. PMID: 27418672 Review.
Malignant brain tumors are highly lethal and aggressive. Despite recent advances in the current therapies, which include the combination of surgery and radio/chemotherapy, the average survival rate remains poor. ...Distinct classes of calcium-permeable channels are …
Malignant brain tumors are highly lethal and aggressive. Despite recent advances in the current therapies, which include the c …
227,172 results
You have reached the last available page of results. Please see the User Guide for more information.